Corrigendum: Neuroprotection after a first episode of mania: A randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume (Translational Psychiatry (2017) 7 (e1011) DOI: 10.1038/tp.2016.281);Neuroprotection after a first episode of mania: A randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

Translational Psychiatry

Volumn 7, Issue 1, 2017, Pages

  Berk, M ^a,b,c,d,e   Dandash, O ^f,g   Daglas, R ^b,c   Cotton, S M ^b,c   Allott, K ^b,c   Fornito, A ^f   Suo, C ^f   Klauser, P ^f,g   Liberg, B ^g,h   Henry, L ^b,c   Macneil, C ^b   Hasty, M ^b   McGorry, P ^b,c   Pantelis, C S ^e,g   Yocel M ^f  

^a DEAKIN UNIVERSITY   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d BARWON HEALTH   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h Clinical Neuroscience   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; QUETIAPINE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; TRANQUILIZER;

ADOLESCENT; ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN SIZE; CAPSULA INTERNA; CEREBELLUM; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; INFERIOR FRONTAL GYRUS; LITHIUM BLOOD LEVEL; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MALE; MANIA; MENTAL PATIENT; MONOTHERAPY; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOXEL BASED MORPHOMETRY; WHITE MATTER; BIPOLAR DISORDER; DIAGNOSTIC IMAGING; MAINTENANCE CHEMOTHERAPY; ORGAN SIZE; PATHOLOGY; YOUNG ADULT;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; GRAY MATTER; HUMANS; LITHIUM COMPOUNDS; MAINTENANCE CHEMOTHERAPY; MALE; NEUROPROTECTIVE AGENTS; ORGAN SIZE; QUETIAPINE FUMARATE; SINGLE-BLIND METHOD; WHITE MATTER; YOUNG ADULT;

EID: 85024376831     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2017.13     Document Type: Erratum

References (61)

1. Kessing LV, Andersen PK, Mortensen PB, Bolwig TG. Recurrence in affective disorder. I. Case register study. Br J Psychiatry 1998; 172: 23-28.
2. Kraepelin E. Manic-Depressive Insanity and Paranoia. Arno Press: New York, NY, USA, 1976, pp xv 280.
3. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
4. Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargel AA, Kunz M et al. Staging and neuroprogression in bipolar disorder. Curr Psychiatr Rep 2012; 14: 667-675.
5. Hawton K, Sutton L, Haw C, Sinclair J, Harriss L. Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. Clin Psychiatry 2005; 66: 693-704.
6. Matza LS, Rajagopalan KS, Thompson CL, de Lissovoy G. Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. J Clin Psychiatry 2005; 66: 1432-1440.
7. Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sole B et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 2010; 123: 81-86.
8. Rosa AR, Gonzalez-Ortega I, Gonzalez-Pinto A, Echeburua E, Comes M, Martinez-Aran A et al. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand 2012; 125: 335-341.
9. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 2002; 52: 93-100.
10. Sassi RB, Brambilla P, Hatch JP, Nicoletti MA, Mallinger AG, Frank E et al. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 2004; 56: 467-475.
11. Ekman CJ, Lind J, Ryden E, Ingvar M, Landen M. Manic episodes are associated with grey matter volume reduction-A voxel-based morphometry brain analysis. Acta Psychiatr Scand 2010; 122: 507-515.
12. Bora E, Fornito A, Yucel M, Pantelis C. Voxelwise meta-Analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 2010; 67: 1097-1105.
13. Javadapour A, Malhi GS, Ivanovski B, Chen X, Wen W, Sachdev P. Hippocampal volumes in adults with bipolar disorder. J Neuropsychiatr Clin Neurosci 2010; 22: 55-62.
14. Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007; 62: 894-900.
15. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J et al. Ventricular and periventricular structural volumes in first-versus multiple-episode bipolar disorder. Am J Psychiatry 2002; 159: 1841-1847.
16. Daglas R, Yucel M, Cotton S, Allott K, Hetrick S, Berk M. Cognitive impairment in first-episode mania: A systematic review of the evidence in the acute and remission phases of the illness. Int J Bipolar Disord 2015; 3: 9.
17. Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 2012; 69: 16-26.
18. de Castro-Manglano P, Mechelli A, Soutullo C, Gimenez-Amaya J, Ortuno F, McGuire P. Longitudinal changes in brain structure following the first episode of psychosis. Psychiatr Res 2011; 191: 166-173.
19. Bora E, Pantelis C. Meta-Analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls. Schizophr Bull 2015; 41: 1095-1104.
20. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology 2010; 35: 1743-1750.
21. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: A cross-sectional and longitudinal MRI study. Biol Psychiatry2007; 62: 773-783.
22. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW et al. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 2009; 70: 699-705.
23. Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML. Effects of medication on neuroimaging findings in bipolar disorder: An updated review. Bipolar Disord 2012; 14: 375-410.
24. Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M et al. Brain volume changes after withdrawal of atypical antipsychotics in patients with firstepisode schizophrenia. J Clin Psychopharmacol 2011; 31: 146-153.
25. Navari S, Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med 2009; 39: 1763-1777.
26. Yang C, Wu S, Lu W, Bai Y, Gao H. Brain differences in first-episode schizophrenia treated with quetiapine: A deformation-based morphometric study. Psychopharmacology 2015; 232: 369-377.
27. Ebdrup BH, Skimminge A, Rasmussen H, Aggernaes B, Oranje B, Lublin H et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 2011; 14: 69-82.
28. First MB, Spitzer Robert L, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). Biometrics Research, New York State Psychiatric Institute: New York, NY, USA, 2002.
29. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
30. Ventura JLD, Nuechterlein KH, Lieberman RP, Green M, Shaner A. Brief Psychiatric Ratings Scale (BPRS) Expanded Version (4.0) scales, anchor points and administration manual. Int J Methods Psychiatr Res 1993; 3: 227-243.
31. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatr Res 1997; 73: 159-171.
32. Mugler JP 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990; 15: 152-157.
33. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007; 38: 95-113.
34. Smith SM, Nichols TE. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009; 44: 83-98.
35. Bora E, Pantelis C. Structural trait markers of bipolar disorder: disruption of white matter integrity and localized gray matter abnormalities in anterior fronto-limbic regions. Biol Psychiatry 2011; 69: 299-300.
36. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: A meta-Analysis. Schizoph Res 2010; 117: 1-12.
37. Hajek T, Cullis J, Novak T, Kopecek M, Blagdon R, Propper L et al. Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus. Biol Psychiatry 2013; 73: 144-152.
38. Watson DR, Anderson JM, Bai F, Barrett SL, McGinnity TM, Mulholland CC et al. A voxel based morphometry study investigating brain structural changes in first episode psychosis. Behav Brain Res 2012; 227: 91-99.
39. Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 2013; 37: 418-435.
40. De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: A meta-Analysis of controlled magnetic resonance imaging studies. Curr Pharm Design 2012; 18: 486-494.
41. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ et al. Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. Lancet 2003; 361: 281-288.
42. Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE et al. Structural magnetic resonance imaging in bipolar disorder: An international collaborative mega-Analysis of individual adult patient data. Biol Psychiatry 2011; 69: 326-335.
43. Amann BL, Canales-Rodriguez EJ, Madre M, Radua J, Monte G, Alonso-Lana S et al. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder. Acta Psychiatr Scand 2015; 133: 23-33.
44. Kalmar JH, Wang F, Spencer L, Edmiston E, Lacadie CM, Martin A et al. Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorder. J Int Neuropsychol Soc 2009; 15: 476-481.
45. Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Lee CU, McCarley RW et al. Follow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophr Res 2004; 71: 349-351.
46. Chaddock CA, Barker GJ, Marshall N, Schulze K, Hall MH, Fern A et al. White matter microstructural impairments and genetic liability to familial bipolar I disorder. Br J Psychiatry 2009; 194: 527-534.
47. Haznedar MM, Roversi F, Pallanti S, Baldini-Rossi N, Schnur DB, LiCalzi EM et al. Fronto-Thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry 2005; 57: 733-742.
48. Gildengers AG, Butters MA, Aizenstein HJ, Marron MM, Emanuel J, Anderson SJ et al. Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder. Bipolar disorders 2015; 17: 248-256.
49. Germana C, Kempton MJ, Sarnicola A, Christodoulou T, Haldane M, Hadjulis M et al. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand 2010; 122: 481-487.
50. Kato T, Fujii K, Kamiya A, Kato N. White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder: A preliminary observation. Psychiatr Clin Neurosci 2000; 54: 117-120.
51. Makoukji J, Belle M, Meffre D, Stassart R, Grenier J, Shackleford G et al. Lithium enhances remyelination of peripheral nerves. Proc Natl Acad Sci USA 2012; 109: 3973-3978.
52. Benedetti F, Bollettini I, Barberi I, Radaelli D, Poletti S, Locatelli C et al. Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology 2013; 38: 313-327.
53. Meffre D, Massaad C, Grenier J. Lithium chloride stimulates PLP and MBP expression in oligodendrocytes via Wnt/beta-catenin and Akt/CREB pathways. Neuroscience 2015; 284: 962-971.
54. Bauer IE, Ouyang A, Mwangi B, Sanches M, Zunta-Soares GB, Keefe RS et al. Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: A diffusion tensor imaging study. J Psychiatr Res 2015; 62: 115-122.
55. Bollettini I, Poletti S, Locatelli C, Vai B, Smeraldi E, Colombo C et al. Disruption of white matter integrity marks poor antidepressant response in bipolar disorder. J Affect Disord 2015; 174: 233-240.
56. Benedetti F, Bollettini I. Recent findings on the role of white matter pathology in bipolar disorder. Har Rev Psychiatry 2014; 22: 338-341.
57. Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ, Disorders Wtfotgf B. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004; 5: 120-135.
58. Yamada S, Takahashi S, Ukai S, Tsuji T, Iwatani J, Tsuda K et al. Microstructural abnormalities in anterior callosal fibers and their relationship with cognitive function in major depressive disorder and bipolar disorder: A tract-specific analysis study. J Affect Disord 2015; 174: 542-548.
59. Katagiri N, Pantelis C, Nemoto T, Zalesky A, Hori M, Shimoji K et al. A longitudinal study investigating sub-Threshold symptoms and white matter changes in individuals with an 'at risk mental state' (ARMS). Schizophr Res 2015; 162: 7-13.
60. Roybal DJ, Barnea-Goraly N, Kelley R, Bararpour L, Howe ME, Reiss AL et al. Widespread white matter tract aberrations in youth with familial risk for bipolar disorder. Psychiatr Res 2015; 232: 184-192.
61. Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M et al. Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry study. Neurosci Lett 2007; 429: 7-11.